Long-term fracture risk among women with proven endometriosis
article
OA: closed
CC0
⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the long-term risk of fractures in women diagnosed with endometriosis, comparing it to women without the condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (61)
- Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? via openalex
- Bone density in women with endometriosis. via openalex
- Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. via openalex
- Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol via openalex
- Evidence that the loss of bone mass induced by GnRH agonists is not totally recovered via openalex
- Gonadotrophin - releasing hormone analogues for endometriosis: bone mineral density via openalex
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex
- INCIDENCE OF PELVIC ENDOMETRIOSIS IN ROCHESTER, MINNESOTA, 1970–1979 via openalex
- Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up via openalex
- Nafarelin therapy in endometriosis: Long-term effects on bone mineral density via openalex
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex
- Reduced Bone Mass in Reproductive-Aged Women with Endometriosis* via openalex
- Reduction of bone mineral density by gonadotropin‐releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration via openalex
- Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. via openalex
- The epidemiology of endometriosis via openalex
- The impact of bone loss in women with endometriosis via openalex
- Total and regional bone mass values and biochemical markers of bone remodeling in endometriosis. via openalex
- Women of Reproductive Age with Endometriosis are Not Osteopenic via openalex
- W2065224313 via openalex
- W2090185696 via openalex
- W2093089036 via openalex
- W2108063837 via openalex
- W2124011858 via openalex
- W2126070576 via openalex
- W2137393443 via openalex
- W2160287478 via openalex
- W2212831907 via openalex
- W2242810181 via openalex
- W2287757320 via openalex
- W2324682309 via openalex
- W2398742257 via openalex
- W2407686213 via openalex
- W2796700885 via openalex
- W88676188 via openalex
- W6655287665 via openalex
- W6672127118 via openalex
- W6688044186 via openalex
- W6714902491 via openalex
- W6717193529 via openalex
- W4293241248 via openalex
- W142500578 via openalex
- W1570622790 via openalex
- W1963947891 via openalex
- W1966813919 via openalex
- W1967446803 via openalex
- W1971909806 via openalex
- W1977365834 via openalex
- W1979300931 via openalex
- W1986238913 via openalex
- W1993192474 via openalex
- W1997258883 via openalex
- W1999996730 via openalex
- W2007225257 via openalex
- W2033401946 via openalex
- W2034500438 via openalex
- W2039901604 via openalex
- W2040717245 via openalex
- W2050587934 via openalex
- W2051862321 via openalex
Cited by (6)
- Endometriosis and menopausal health: An EMAS clinical guide 2025
- Relationship between bone mineral density and ovarian function and thyroid function in perimenopausal women with endometriosis: a prospective study 2022
- Relationship Between Bone Mineral Density and Ovarian Function in Perimenopausal Women With Endometriosis: A Prospective Study 2021
- Bone mineral density in women with deep infiltrating endometriosis who have undergone early bilateral oophorectomy 2020
- Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation 2015
- Long-term fracture risk among women with proven endometriosis 2008
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:12.369988+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK